期刊文献+

Zacopride缺血后适应抑制大鼠缺血/再灌注性心律失常 被引量:3

Postconditioning of zacopride depresses ischemia / reperfusion-induced arrhythmias in rats
下载PDF
导出
摘要 目的:探讨心肌内向整流钾通道(Kir)激动剂zacopride缺血后适应对大鼠缺血/再灌注性心律失常的影响及可能的电生理学机制。方法:SD大鼠Langendorff离体灌流心脏和在体麻醉大鼠冠状动脉左前降支结扎15 min后松扎15 min诱发缺血/再灌注性心律失常。在冠状动脉左前降支松扎前3 min给予zacopride,观察缺血后适应对再灌注性心律失常的影响。胶原酶法分离大鼠单个心室肌细胞,应用全细胞膜片钳技术观察zacopride对心室肌细胞缺氧/复氧致延迟后除极的影响和对细胞膜表面ATP敏感性钾通道(KATP)的影响。结果:大鼠离体心脏再灌注时预先给予0.1~10μmol/L zacopride可有效抑制再灌注性心律失常的发生。其中0.1μmol/L zacopride为最大效应浓度,可使期前收缩数减少,室速和室颤发生率均下降,持续时间均缩短;再灌前3 min将1μmol/L BaCl2和0.1μmol/L zacopride同时灌流心脏,BaCl2可部分逆转zacopride的保护效应(P〈0.01),表明zacopride的后适应保护与其增强Kir电流的作用有关。在1.5~5μg/kg剂量范围内,zacopride对大鼠在体再灌注诱发的室速和室颤有明显抑制效应,但对期前收缩数无明显影响。1.5μg/kg zacopride抗心律失常的效应与阳性对照药利多卡因(7.5 mg/kg)相似。进一步研究发现zacopride可有效抑制缺氧/复氧所致心室肌细胞延迟后除极,降低其发生率(P〈0.01)。Zacopride的上述效应与K(ATP)无关。结论:Zacopride对大鼠缺血/再灌注性心律失常的抑制作用是由激活心肌细胞Kir介导的。激活Kir并消除延迟后除极所诱发的触发性活动可能是zacopride缺血后适应的主要机制。 AIM: To investigate the effects of postconditioning of zacopride,a specific agonist of inwardly rectifying potassium channel( Kir),on ischemia/reperfusion-induced arrhythmias and the involved electrophysiological mechanisms. METHODS: Langendorff-perfused SD rat hearts or anesthetized rats were subjected to coronary artery occlusion for15 min followed by 15 min of reperfusion to induce ischemia / reperfusion arrhythmias. Zacopride was applied 3 min before reperfusion. Various arrhythmias were monitored and compared in different groups. The single rat ventricular myocyte was isolated by collagenase digestion. The effects of zacopride on hypoxia / reoxygenation-induced delayed afterdepolarizations( DADs) and ATP-sensitive potassium channel( K(ATP)) were observed by the technique of whole-cell patch clamping. RESULTS: Post-conditioning of 0. 1 ~ 10 μmol / L zacopride significantly prevented the hearts from reperfusion arrhythmias.During reperfusion,0. 1 μmol / L zacopride showed the maximum effect,with decreasing the number of premature ventricu-lar beats( PVB),reducing the incidences of ventricular tachycardia( VT) and ventricular fibrillation( VF),and shortening the duration of VT and VF( P〈0. 01). The postconditioning effects were partly reversed by 1 μmol / L BaCl2( P〈0. 01),suggesting that the antiarrhythmic effect of zacopride was mediated by Kir. In the in vivo study,1. 5 ~ 5 μg /kg zacopride had positive effects on reperfusion-induced VT and VF and negative effect on PVB. At the dose of 1. 5 μg / kg,zacopride showed the most potent antiarrhythmic effect,which compared favourably with that of a classical antiarrhythmic agent,lidocaine. Furthermore, zacopride significantly inhibited hypoxia / reoxygenation-induced DADs( P〈0. 01).Zacopride had no effect on K ATP. CONCLUSION: The inhibitory effect of zacopride on ischemia / reperfusion-induced arrhythmias is mediated by the activation of Kir. Augmentation of Kir cuvrent,thus diminishing the DADs,might be the critical mechanisms underlying postconditioning of zacopride.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2016年第11期1921-1927,共7页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.31200864) 中央高校基本科研业务费专项资金资助课题(No.2015SYS008) 山西医科大学创新基金(No.01201107)
关键词 Zacopride 心律失常 后适应 内向整流钾通道 延迟后除极 Zacopride Arrhythmia Postconditioning Inwardly rectifying potassium channel Delayed afterdepolarizations
  • 相关文献

参考文献1

二级参考文献8

共引文献22

同被引文献20

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部